Blue Crest Capital Management LTD Ampio Pharmaceuticals, Inc. Transaction History

Blue Crest Capital Management LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$0.39 - $0.7 $38,470 - $69,049	-98,642 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$0.44 - $3.02 $43,402 - $297,898	98,642 New	98,642 $50,000
Q2 2018 Aug 14, 2018	SELL	$1.66 - $3.82 $516,686 - $1.19 Million	-311,257 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$2.16 - $3.48 $672,315 - $1.08 Million	311,257 New	311,257 $1.06 Million

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Blue Crest Capital Management LTD with notifications on news.